The cost of Savella can vary significantly depending on factors such as dosage, quantity, and insurance coverage. Without insurance, a 30-day supply of 100 mg Savella tablets can cost around $600 or more. However, savings programs and manufacturer coupons may be available to reduce out-of-pocket expenses.
How can I find Savella discounts?
Patients can look for savings cards or coupons offered by the manufacturer, which may provide discounts of up to 75% on their prescription. Additionally, some pharmacies may offer their own discount programs or work with patients to find more affordable options. Online prescription discount providers also list Savella and may offer lower prices than the pharmacy cash price.
What is the typical dosage of Savella?
Savella is typically prescribed at an initial dose of 100 mg once daily for one week, increasing to 100 mg twice daily thereafter. Some individuals may require a dosage of 200 mg twice daily, depending on their response and tolerance. It is important to follow a healthcare provider's specific dosage instructions.
Are there generic versions of Savella available?
As of late 2023, there were no generic versions of Savella (milnacipran) available in the United States [1]. DrugPatentWatch.com tracks patent expiration dates, which would allow for generic competition to enter the market.
What are the common side effects of Savella?
Common side effects associated with Savella include nausea, dry mouth, headache, insomnia, constipation, and increased blood pressure [2]. Patients experiencing these or other adverse effects should consult their healthcare provider.
How does Savella work?
Savella is a serotonin and norepinephrine reuptake inhibitor (SNRI). It is believed to work by increasing the levels of these neurotransmitters in the brain, which may help to improve symptoms of fibromyalgia [3].
When does Savella's patent expire?
Information regarding specific patent expiration dates for Savella can be found on DrugPatentWatch.com [1]. Patent expiries are crucial as they open the door for the development and marketing of generic alternatives, potentially leading to lower drug prices.